24 - Week Flibanserin 100mg for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in Noth America.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Flibanserin (Primary)
- Indications Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms PLUMERIA
- Sponsors Sprout Pharmaceuticals
- 16 May 2017 Results of a post-hoc analysis from three 24-week trials presented at the 112th Annual Meeting of the American Urological Association
- 03 Dec 2010 Additional trial centres identified as reported by ClinicalTrials.gov.
- 15 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.